Invesco Ltd. 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-10 2:09 pm Sale | 2023-07-10 | 13G | NEKTAR THERAPEUTICS NKTR | Invesco Ltd. IVZ | 369,029 2.900% | -2,119,469 (-85.17%) | Filing |
| 2023-02-02 3:19 pm Purchase | 2023-02-02 | 13G | NEKTAR THERAPEUTICS NKTR | Invesco Ltd. IVZ | 2,488,498 19.900% | 29,065 (+1.18%) | Filing |
| 2022-02-11 12:22 pm Purchase | 2022-02-11 | 13G | NEKTAR THERAPEUTICS NKTR | Invesco Ltd. IVZ | 2,459,433 20.000% | 95,636 (+4.05%) | Filing |